Concepedia

Christine Guntermann

CG

Statistics

Publications

22

Citations

1K

H-Index

16

Active since

1995

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

St Bartholomew's Hospital

King's College London

Spanish Oncology Genitourinary Group

Christine Guntermann is an author at Novartis (Switzerland) specializing in immunology, life sciences, and signal transduction.

ORCID

Publications per year

1995–2020

22

Publications

22

c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

Jochem H. Bernink, Yoichiro Ohne, Marcel B. M. Teunissen et al. · Nature Immunology · 2019 · 192 citations · Full text

, , +15

The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation

Jean-Pierre Evenou, Jürgen Wagner, Gerhard Zenke et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 160 citations

, , +17

CTLA-4 Suppresses Proximal TCR Signaling in Resting Human CD4+ T Cells by Inhibiting ZAP-70 Tyr319 Phosphorylation: A Potential Role for Tyrosine Phosphatases

Christine Guntermann, Denis R. Alexander · The Journal of Immunology · 2002 · 127 citations · Full text

, , +17

Structural States of RORγt: X‐ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds

Joerg Kallen, Aude Izaac, C. Be et al. · ChemMedChem · 2017 · 64 citations

, , +16

Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo

Ulf Guendisch, Jessica Weiss, Florence Ecoeur et al. · PLoS ONE · 2017 · 64 citations · Full text

, , +17

1–5 of 22